The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy-Reference-Cited by-同舟云学术

The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy

Published:2021-07 Issue: Volume:Volume 13 Page:5297-5307
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Xiang Zhanwang,Zhong Zhihui,Mu Luwen^ORCID,Li Guohong,Zhou Churen^ORCID,Wang Haofan,Huang Mingsheng^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference35 articles.

1. Non–Small-Cell Lung Cancer — Stalemate or Progress?

2. Multimodality Treatment With Surgery for Locally Advanced Non–Small-Cell Lung Cancer With N2 Disease: A Review Article

3. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

5. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in radioactive seed implantation brachytherapy of non-small cell lung cancer: a narrative review;Journal of Thoracic Disease;2024-03

2. I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis;Journal of Cardiothoracic Surgery;2022-04-12

3. Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches;Materials Advances;2022